Oxaliplatin may induce nuclear accumulation of RFNG in CRC cells with high ERK activity, and in CRC cells with low ERK activity, oxaliplatin may not be necessary to elicit the function of nuclear RFNG. This evidence concerns the gene MAPK1 and colorectal carcinoma.